NCT03319290View on ClinicalTrials.gov

Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

UnknownOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

October 17, 2020

Conditions
Hereditary Cancer
Interventions
GENETIC

BRCA1 and BRCA2

Genetic breast and ovarian cancer testing

Trial Locations (1)

33558

DCABM, Land O' Lakes

Sponsors

Collaborators (1)

PAS Research Services
All Listed Sponsors
collaborator

PAS Research Services

OTHER

lead

Data Collection Analysis Business Management

OTHER